Bioadaptives, Inc. (BDPT) Return on Sales (2016 - 2026)
Bioadaptives (BDPT) posted Return on Sales of 0.2% for Q1 2026, up 74.49% sequentially from 0.79% in Q4 2025, and up 1150.0% YoY from 0.02% in Q1 2025.
Bioadaptives, Inc. (BDPT) Return on Sales (2016 - 2026) Analysis & Trends
Bioadaptives has reported Return on Sales for 9 years, with the latest figure at 0.2% in Q1 2026.
- Quarterly Return on Sales rose 1150.0% year-over-year to 0.2% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.62% (up 1108.0% YoY) and the FY2025 annual result came in at 0.85%, down 14.0% from the prior year.
- Return on Sales improved to 0.2% in Q1 2026 per BDPT's latest filing, from 0.79% in the prior quarter.
- Over five years, Return on Sales peaked at 0.07% in Q3 2023 and troughed at 11.7% in Q1 2025.
- A 5-year average of 1.19% and a median of 0.49% in 2025 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2025 and 2026: Return on Sales sank 1161 bps in 2025, then surged 1150 bps in 2026.
- Over 5 years, Return on Sales stood at 0.1% in 2022, then plunged by 49 bps to 0.15% in 2023, then slumped by 278 bps to 0.55% in 2024, then tumbled by 44 bps to 0.79% in 2025, then jumped by 74 bps to 0.2% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.2%, 0.79%, and 0.82% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.20% |
| Dec 31, 2025 | -0.79% |
| Sep 30, 2025 | -0.82% |
| Jun 30, 2025 | -0.49% |
| Mar 31, 2025 | -11.70% |
| Dec 31, 2024 | -0.55% |
| Sep 30, 2024 | -0.22% |
| Jun 30, 2024 | -2.71% |
| Mar 31, 2024 | -0.09% |
| Dec 31, 2023 | -0.15% |
| Sep 30, 2023 | -0.07% |
| Jun 30, 2023 | -0.46% |
| Mar 31, 2023 | -0.21% |
| Dec 31, 2022 | -0.10% |
| Sep 30, 2022 | -0.51% |
| Jun 30, 2022 | -0.51% |
| Mar 31, 2022 | -0.66% |
| Dec 31, 2021 | -0.56% |
| Sep 30, 2021 | -0.06% |
| Jun 30, 2021 | -0.51% |